Liu and his team found that high expression of IGF2BP3 in clear cell ovarian carcinoma was associated with poor prognosis, and IGF2BP3 was also confirmed to promote the occurrence of clear cell ovarian carcinoma in vivo and in vitro [48]. This evidence concerns the gene IGF2BP3 and ovarian clear cell cancer.